Institutional investors purchased a net $1.7 million shares of VCEL during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 29.89% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STONEPINE CAPITAL MANAGEMENT LLC Bought 860.8 Thousand shares of Vericel Corp
CONSONANCE CAPITAL MANAGEMENT LP Bought 750.0 Thousand shares of Vericel Corp
ALYESKA INVESTMENT GROUP LP Bought 687.7 Thousand shares of Vericel Corp